Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

Clinical trial NCT01698918 · COMPLETED

Trial details

NCT number

NCT01698918

Sponsor

Novartis Pharmaceuticals

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-03-07

Primary completion

2015-12-17

Enrollment

202

View on ClinicalTrials.gov